Showing results (211-220 of 261) with videos related to

Sort By:
Pageof 27
Oncotarget|January 11, 2015
PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant gliomaJara Majuelos-Melguizo, María Isabel Rodríguez, Laura López-Jiménez, et al.
The Journal of Investigative Dermatology|March 29, 2002
PTEN mutations in eight Spanish families and one Brazilian family with Cowden syndromeElena Bussaglia, Ramon M Pujol, M Jesus Gil, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 30, 2011
Statistical parametric maps of ¹⁸F-FDG PET and 3-D autoradiography in the rat brain: a cross-validation studyElena Prieto, María Collantes, Mercedes Delgado, et al.
Cerebral Cortex (New York, N.Y. : 1991)|November 21, 2008
Cortical atrophy and language network reorganization associated with a novel progranulin mutationCarlos Cruchaga, Maria A Fernández-Seara, Manuel Seijo-Martínez, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 30, 2013
Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementiaJavier Arbizu, E Prieto, P Martínez-Lage, et al.
Revista Espanola De Medicina Nuclear|March 28, 2008
[Use of 11C-(+)-alpha -dihydrotetrabenazine for the assessment of dopaminergic innervation in animal models of Parkinson's disease]M Collantes, I Peñuelas, L Alvarez-Erviti, et al.
Cancers|October 23, 2021
<i>BRAF</i> Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic CharacteristicsXavier Soria, Felip Vilardell, Óscar Maiques, et al.
Life (Basel, Switzerland)|December 23, 2022
Association of TYR SNP rs1042602 with Melanoma Risk and PrognosisArrate Sevilla, Ana Sánchez-Diez, Sofía Cobo, et al.
Revista Espanola De Medicina Nuclear|January 23, 2008
[Quick and simple synthesis of (11)C-(+)-alpha-dihydrotetrabenazine to be used as a PET radioligand of vesicular monoamine transporters]G Quincoces, M Collantes, R Catalán, et al.
International Journal of Cancer|March 30, 2011
Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathwayAndree Yeramian, Anabel Sorolla, Ana Velasco, et al.
Pageof 27